Sriram Ryali

Insider Reports History

Entity
Individual
Location
C/O Eiger Biopharmaceuticals, Inc., 2155 Park Blvd., Palo Alto, CA
Signature
/s/ Sriram Ryali
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sriram Ryali:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CODEXIS, INC. Chief Financial Officer Common Stock 176K $371K $2.11 Jan 1, 2024 Direct
Eiger BioPharmaceuticals, Inc. Chief Financial Officer Common Stock 41.6K $12.4K $0.30 Mar 14, 2022 Direct
CODEXIS, INC. Chief Financial Officer Stock Option (Right to Buy) 314K Jan 1, 2024 Direct
Eiger BioPharmaceuticals, Inc. Chief Financial Officer Stock Option (Right to Buy) 143K Mar 11, 2022 Direct

Insider Reports Filed by Sriram Ryali

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CDXS CODEXIS, INC. Jan 1, 2024 2 $0 4 Jan 2, 2024 Chief Financial Officer
CDXS CODEXIS, INC. Sep 8, 2023 1 $19.9K 4 Sep 12, 2023 Chief Financial Officer
CDXS CODEXIS, INC. Feb 10, 2023 2 $0 4 Feb 14, 2023 Chief Financial Officer
CDXS CODEXIS, INC. Jan 23, 2023 0 $0 3 Jan 25, 2023 Chief Financial Officer
EIGR Eiger BioPharmaceuticals, Inc. Mar 14, 2022 1 -$12.7K 4 Mar 14, 2022 Chief Financial Officer
EIGR Eiger BioPharmaceuticals, Inc. Mar 11, 2022 2 $0 4 Mar 11, 2022 Chief Financial Officer
EIGR Eiger BioPharmaceuticals, Inc. Jul 29, 2021 1 $0 4 Jul 30, 2021 Chief Financial Officer
EIGR Eiger BioPharmaceuticals, Inc. May 10, 2021 1 $0 4 May 11, 2021 Chief Financial Officer